Veradermics (VDPHL01): Accelerating Hair Loss Outcomes and Social Listening Insights Support Buy/High-Risk Rating and $85 Target
at www.tipranks.com (Tue, 31-Mar 6:25 AM)
Tango Therapeutics is the best performing healthcare stock in March
at seekingalpha.com (Mon, 30-Mar 2:10 PM)
Veradermics reports Q4 results
at seekingalpha.com (Mon, 30-Mar 7:40 AM)
